Saturday, August 12, 2017

A Cancer Conundrum: Too Many Drug Trials, Too Few Patients


By GINA KOLATA from NYT Health A Cancer Conundrum: Too Many Drug Trials, Too Few Patients
Breakthroughs in immunotherapy and a rush to develop profitable new treatments have brought a crush of clinical trials scrambling for patients. Read more article at hafana

No comments:

Post a Comment